6-Bromo-5-fluoro-1H-indazole(CAS: 1286734-85-7)

6-Bromo-5-fluoro-1H-indazole (CAS: 1286734-85-7) should comply with the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements. GHS provides hazard classification and labeling guidance, while REACH focuses on the registration, evaluation, authorization, and restriction of chemicals. FDA and EPA regulations ensure safe manufacturing, handling, and environmental protection during its use and disposal in the United States.

Several alternatives to 6-Bromo-5-fluoro-1H-indazole exist in synthesis, including 6-fluoro-5-chloro-1H-indazole and 6-bromo-5-chloro-1H-indazole. These compounds can serve similar roles in chemical reactions. Other substitutes include using different functional groups or structural modifications to achieve the desired properties in the target molecule.

The market for 6-Bromo-5-fluoro-1H-indazole (CAS: 1286734-85-7) is growing due to its applications in pharmaceuticals and materials science. Research trends focus on its use as an intermediate in drug discovery, particularly in antiviral and anticancer therapies. Market demand is also driven by its potential in developing new materials with specific properties. However, the market is expected to be highly competitive, with ongoing research exploring cost-effective syntheses and new applications.

Waste containing 6-Bromo-5-fluoro-1H-indazole (CAS: 1286734-85-7) should be managed according to local and federal regulations. Collection should be done in sealed, compatible containers, and proper labeling is essential. Incineration or professional waste disposal services are recommended for disposal. Environmental protection measures include ensuring no pollutants are released into the air or water during handling and disposal. Always consult the Material Safety Data Sheet (MSDS) and local regulations for specific guidelines.